Cellipont Bioservices and WuGen News and Resources

Cellipont Bioservices, a cell therapy Contract Development and Manufacturing Organization (CDMO), and WuGen, Inc., a clinical-stage biotechnology company, have announced the signing of an agreement for the manufacturing of their CAR-T cell therapies. The agreement was signed on March 14,